2010
DOI: 10.1007/s00223-010-9350-7
|View full text |Cite
|
Sign up to set email alerts
|

Genetic Analysis of Lrp5 Function in Osteoblast Progenitors

Abstract: The low-density lipoprotein receptor-related protein (Lrp)-5 regulates osteoblast proliferation and bone formation through its expression in duodenum by modifying the gut serotonin-bone endocrine axis. However, its direct role, if any, in osteoblast progenitor cells has not been studied thus far. Here, we show that mice with a Dermo1-Cre-mediated disruption of Lrp5 in osteoblast progenitor cells have normal embryonic skeletogenesis and normal skeletal growth and development postnatally. Histomorphometric analy… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

5
20
1

Year Published

2011
2011
2017
2017

Publication Types

Select...
8
1

Relationship

2
7

Authors

Journals

citations
Cited by 30 publications
(26 citation statements)
references
References 30 publications
5
20
1
Order By: Relevance
“…As a consequence, serum levels of serotonin were increased in Lrp5 knock-out homozygous and heterozygous mice. Their findings are in agreement with numerous clinical observations in OPPG and HBM patients [45-47] and suggest that altered LRP5 functionality may be acting on bone at a distance by regulating circulating levels of serotonin, which would then bind to specific receptors on bone cells, and not directly by controlling Wnt signaling in bone cells, as commonly maintained (Figure 1). Strikingly, ex vivo experiments revealed that 50 mM 5-HT could indeed stop osteoblast proliferation by binding to the HTR1B receptor and activating PKA and CREB transcription factor [44], although previous independent results showed that lower (0.1 mM) doses of serotonin could enhance the proliferation of human primary osteoblasts in vitro [48], suggesting a possible dose-dependent effect.…”
Section: The Wnt Connectionsupporting
confidence: 90%
“…As a consequence, serum levels of serotonin were increased in Lrp5 knock-out homozygous and heterozygous mice. Their findings are in agreement with numerous clinical observations in OPPG and HBM patients [45-47] and suggest that altered LRP5 functionality may be acting on bone at a distance by regulating circulating levels of serotonin, which would then bind to specific receptors on bone cells, and not directly by controlling Wnt signaling in bone cells, as commonly maintained (Figure 1). Strikingly, ex vivo experiments revealed that 50 mM 5-HT could indeed stop osteoblast proliferation by binding to the HTR1B receptor and activating PKA and CREB transcription factor [44], although previous independent results showed that lower (0.1 mM) doses of serotonin could enhance the proliferation of human primary osteoblasts in vitro [48], suggesting a possible dose-dependent effect.…”
Section: The Wnt Connectionsupporting
confidence: 90%
“…The potential stage specificity of LRP5 function was addressed by two different groups but with conflicting results. Whereas one group reported that deletion of Lrp5, either in mature osteoblasts (ColI-Cre) 8 Cite this article as Cold Spring Harb Perspect Biol 2013;5:a008334 (Yadav et al 2008) or in mesenchymal progenitors (Dermo1-Cre, and therefore all cells of the osteoblast lineage) (Yadav et al 2010), did not produce any bone phenotype, a second group showed that deletion of Lrp5 predominantly in osteocytes (differentiated from osteoblasts; Dmp1-Cre) 9 resulted in less bone (Cui et al 2011). The different findings support competing models.…”
Section: Wnt Proteinsmentioning
confidence: 99%
“…Subsequently, osteogenesis is induced through differentiation of mesenchymal cells into osteoblasts and suppression of osteoblasts apoptosis, and concomitantly, bone resorption is suppressed through inhibition of osteoclast differentiation (15,16). Recently, mutated LRP-5 has been identified as the causative gene for osteoporosis-pseudoglioma syndrome (OPPG), and has been found to be involved in bone metabolism-related disease (3,36). Moreover, inhibition of DKK-1, an LRP-5 inhibitory factor, or SFRP-1 and SFRP-2, the Wnt inhibitory factors, results in enhanced osteogenesis (26,34).…”
Section: Discussionmentioning
confidence: 99%